Top compounds associated with response to CCDC142


Feature Type Standardized
Nominal ANOVA
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.18 4e-07
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.16 9e-06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 6e-05
mRNA tivozanib CTRPv2 pan-cancer AAC -0.14 9e-05
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.11 0.0003
mRNA decitabine CTRPv2 pan-cancer AAC -0.098 0.0004
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.11 0.0005
mRNA pluripotin CTRPv2 pan-cancer AAC -0.12 0.0007
Download CSV